,Date,Title,URL,Journal,Severe,Severe lower bound,Severe upper bound,Severe p-value,Severe Significant,Severe Adjusted,Severe Calculated,Fatality,Fatality lower bound,Fatality upper bound,Fatality p-value,Fatality Significant,Fatality Adjusted,Fatality Calculated,Multivariate adjustment,Design,Sample,Study population,Added on,Critical only,Discharged vs. death?,Sample Text,Matches,Entry
,2020-08-31,Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers,https://doi.org/10.1016/j.dsx.2020.03.016,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,187.0,"Methods We have systematically searched the medical database up to March 27, 2020 and retrieved all the published articles in English language related to our topic using MeSH key words.",,,,"In a study of 187 patients with COVID-19, Guo et al.","found hypertension to have an odds ratio (OR) of 3.05 (95% CI, 1.57 to 5.92; p < 0.006), diabetes with OR of 2.85 (95% CI, 1.35 to 6.05; p < 0.001), whereas presence of coronary artery disease had an OR of 21.40 (95% CI, 4.64 to 98.76; p < 0.0001) for in-hospital mortality, in an univariate analysis .

found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p = 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p = 0.09) for death.",2020-04-17
,2020-08-31,"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations",https://doi.org/10.1016/j.dsx.2020.04.004,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,161.0,"Methods PubMed database and Google Scholar were searched using the key terms ‘COVID-19’, ‘SARS-CoV-2’, ‘diabetes’, ‘antidiabetic therapy’ up to April 2, 2020.",,,,A study in 161 patients with COVID-19 in Wuhan found increased time for viral clearance in patients with diabetes .,"the odds ratio (OR) of severe COVID-19 was not significantly higher in patients with diabetes (OR, 2.07; 95% CI, 0.89 to 4.82), unlike hypertension (OR, 2.36; 95% CI, 1.46 to 3.83) and CVD (OR, 3.42; 95% CI, 1.88 to 6.22).

found diabetes to have an OR of 2.85 (95% CI, 1.35 to 6.05; p < 0.001) for in-hospital mortality.

demonstrated a HR of 1.58 (95% CI, 0.80 to 3.13, p = 0.19) for death in patients with diabetes with COVID-19.",2020-05-12
,2020-07-15,Myocardial injury and COVID-19: Possible mechanisms,https://doi.org/10.1016/j.lfs.2020.117723,Life Sci,,,,,,,,,,,,,,,,Cross-sectional,419.0,"in a single center in Wuhan, China examined mortality associated with CVD comorbidity and troponin T (TnT) elevation on admission .",,,,"In another case-series of 419 cases with COVID-19 in Shenzhen, China, patients were divided into 36 ICU patients and 383 non-ICU patients.","of 1527 patients mostly in Wuhan, China indicated the prevalence of hypertension, cardiac and cerebrovascular disease, and diabetes to be 17.1%, 16.4%, and 9.7% respectively amongst patients with COVID-19.",2020-05-12
,2020-06-30,Epidemiology and clinical features of COVID-19: A review of current literature,https://doi.org/10.1016/j.jcv.2020.104357,Journal of Clinical Virology,,,,,,,,,,,,,,,,Other,10.0,Evaluation of all positive cases from mainland China showed 3.8 % being from healthcare workers (1716/44672) .,,,,tested 445 people that were in close contact (at least 6 feet from the source for a minimum of 10 min) with 10 COVID-19-confirmed patients.,"Comorbidities associated with severe COVID-19 cases include elderly age, hypertension, cardiovascular disease, cerebrovascular disease, and chronic kidney disease .",2020-05-12
,2020-05-31,Coronavirus disease 2019 (COVID-19): A literature review,https://doi.org/10.1016/j.jiph.2020.03.019,Journal of Infection and Public Health,,,,,,,,,,,,,,,,Other,425.0,"Outside China, as of February 12, 2020, there were 441 confirmed COVID-19 cases reported in 24 countries of which the first imported case was reported in Thailand on January 13, 2020 .",,,,"In a study of 425 COVID-19 patients in Wuhan, published on January 29, there were no cases in children under 15 years of age .","SARS-CoV-2 is also more likely to infect people with chronic comorbidities such as cardiovascular and cerebrovascular diseases and diabetes .

The highest proportion of severe cases occurs in adults ≥60 years of age, and in those with certain underlying conditions, such as cardiovascular and cerebrovascular diseases and diabetes .",2020-05-12
,2020-05-08,Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study,https://doi.org/10.1016/j.ajogmf.2020.100134,American Journal of Obstetrics & Gynecology MFM,,,,,,,,,,,,,,,,Other,64.0,"Study Design This is a cohort study of pregnant women with severe or critical COVID-19 infection hospitalized at 12 US institutions between March 5, 2020 and April 20, 2020.",,,,"Results Of 64 pregnant women hospitalized with COVID-19, 44 (69%) had severe and 20 (31%) critical disease.","In one study, patients requiring ICU care were more likely to have comorbid hypertension, cardiovascular disease, diabetes, and cerebrovascular disease 16 .",2020-05-12
,2020-05-08,Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology,https://doi.org/10.1016/j.rec.2020.05.001,Revista Española de Cardiología (English Edition),,,,,,,,,,,,,,,,Other,177.0,Confirmed cases of COVID-19,,,,"8, 9 According to data published by the Spanish Ministry of Health (table 1) , 177 633 patients were diagnosed with COVID-19 in Spain by April 15, 2020 ; of the 57 106 hospitalized individuals, 24.1% were aged between 70 and 79 years, 19% were aged between 80 and 89 years, and 5.1% were older than 90 years.","8, 9 Specifically, a meta-analysis of 6 studies with a total of 1527 patients determined prevalences of hypertension, CVD and cerebrovascular disease, and diabetes of 17.1%, 16.4%, and 9.7%, respectively.",2020-05-12
,2020-05-03,A review of cardiac manifestations and predictors of outcome in patients with COVID – 19,https://doi.org/10.1016/j.hrtlng.2020.04.019,Heart & Lung,,,,,,,,,,,,,,,,Other,90.0,"21, 28 Electrocardiography Data on EKG findings on patients with COVID-19 is scanty.",,,,The study including 90 patients who underwent non contrast computed tomography (CT) of chest reported pericardial effusion in 1% of patients.,"Most studies have shown that patients with cardiovascular risk factors like advanced age, hypertension, DM, cardiovascular diseases, cerebrovascular disease had the worst clinical outcome.

Established cardiovascular risk factors such as diabetes mellitus, hypertension, and coronary artery disease predispose to cardiac injury, the severity of illness and mortality.

15 Across all studies, cardiovascular risk factors like advanced age, hypertension, DM, coronary artery disease, heart failure, atrial fibrillation, cerebrovascular disease have been reported to be associated with increased mortality.

Cardiovascular risk factors in terms of DM, ischemic heart disease, atrial fibrillation and a history of stroke was present in 35.5%, 30%, 24.5%, and 9.6% respectively in a subset of patients who succumbed to the disease.

6, 7 Cardiovascular comorbidities including hypertension, diabetes mellitus (DM), coronary artery disease, heart failure have been reported in larger numbers.",2020-05-12
,2020-04-30,May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?,https://doi.org/10.1016/j.ijantimicag.2020.106003,International Journal of Antimicrobial Agents,,,,,,,,,,,,,,,,Other,,We suggest follow-up ECG evaluations for people who receive hydroxychloroquine and/or azithromycin.,,,,,"Hypertension, diabetes, cardiovascular diseases and cerebrovascular diseases, were highlighted as risk factors for fatality.",2020-05-12
,2020-04-29,Systematic review of international guidelines for tracheostomy in COVID-19 patients.,https://doi.org/10.1101/2020.04.26.20080242,medrxiv,,,,,,,,,,,,,,,,Systematic review,,"This review of international guidelines for tracheostomy in COVID-19 infected patients, aiming to summarize in a systematic way the available recommendations from 18 guidelines from all over the world.",,,,The optimal timing of tracheostomy in patients with COVID-19 is unknown.," Elderly, hypertension, diabetes, chronic obstructive pulmonary disease, cardiovascular disease, and cerebrovascular disease are significant risk factors for COVID-19 patients.

A recent meta-analysis identified hypertension, diabetes, chronic obstructive pulmonary disease, cardiovascular disease, and cerebrovascular disease as significant risk factors for COVID-19 patients.",2020-05-12
,2020-04-29,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.",https://doi.org/10.1101/2020.04.24.20077875,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,610.0,The clinical data of all patients were collected from the electronic medical records.,,,,A total of 610 COVID-19 patients were enrolled after admission from various centers in the Zheijiang province (Figure 1) .,"We find that, prevalence of type 2 diabetes, higher BMI, presence of cardiovascular or cerebrovascular disease were associated with (all increased in) the covid-19 patients ( Table 1) .",2020-05-12
,2020-04-28,Marked Up-Regulation of ACE2 in Hearts of Patients with Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19,https://doi.org/10.1016/j.mayocp.2020.04.028,Mayo Clinic Proceedings,,,,,,,,,,,,,,,,Other,106.0,"All patients undergoing therapeutic surgical septal myectomy for symptomatic relief of obstructive HCM between January 1, 1999 and December 31, 2010 were eligible for inclusion in this study.",,,,Patients and Methods RNA was extracted from cardiac tissue flash frozen at therapeutic surgical septal myectomy for 106 patients with HCM and from 39 healthy donor hearts.,"A large meta-analysis of over 46,000 patients in China showed the most common co-morbidities were HTN (17±7%, 95% CI 14 -22%), diabetes mellitus (8±6% 95% CI 6-11%), and cardiovascular disease (5±4%, 95% CI 4-7%) 31 .",2020-05-01
,2020-04-28,Effectiveness of convalescent plasma therapy in severe COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196837/,Proc Natl Acad Sci U S A,,,,,,,,,,,,,,,,Randomized control trial,10.0,"From January 23, 2020, to February 19, 2020, 10 patients in three participating hospitals (Wuhan Jinyintan Hospital; the Jiangxia District Hospital of Integrative Traditional Chinese and Western Medicine, Wuhan; and the First People’s Hospital of Jiangxia District, Wuhan) were recruited in this pilot study.",,,,Ten donor patients who recovered from COVID-19 were recruited from three participating hospitals.,"Four patients had underlying chronic diseases, including cardiovascular and/or cerebrovascular diseases and essential hypertension.",2020-05-12
,2020-04-27,Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China,https://doi.org/10.1016/j.mad.2020.111255,Mechanisms of Ageing and Development,,,,,,,,,,,,,,,,Case series,154.0,"Due to data availability, clinical data of individuals reported by the media and Chinese health authorities were sought by performing a search on Google.",,,,"A total of 154 individual cases in 26 provinces, including 89 deceased patients and 65 surviving patients, were identified from 86 sources originating from the official web pages of Chinese health authorities and the media under the supervision of the Chinese government such as Xinhua, Sina and the Paper.","The most commonly observed comorbidities in deceased patients were hypertension (53.2%), cardiovascular and cerebrovascular disease (42.0%), and diabetes (37.8%).",2020-05-01
,2020-04-27,Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189076/,J Gynecol Oncol,,,,,,,,,,,,,,,,Other,2.0,"She received three cycles of neoadjuvant paclitaxel-carboplatin from December 12, 2019 to January 28, 2020.",,,,We present two ovarian cancer patients whose treatment courses were affected by the local circumstances of COVID-19 in Daegu.,"In particular, severe cases of COVID-19 often have underlying diseases such as hypertension, cardiovascular disease, cerebrovascular disease, and diabetes mellitus .",2020-05-12
,2020-04-25,COVID-19 Fatality and Comorbidity Risk Factors among Confirmed Patients in Mexico,https://doi.org/10.1101/2020.04.21.20074591,medrxiv,,,,,,,,,,,,,,,,Other,7497.0,"In this paper we estimate fatality risks based on survival analysis methods, calculated from individual-level data on symptomatic patients confirmed with COVID-19 recently released by the Mexican Ministry of Health.",,,,"Our analysis is based on 7,497 patients who tested positive for COVID-19 in Mexico, a subset of a larger dataset of 49,167 patients with COVID-19 related symptoms who sought attention in medical units and were tested with positive, negative (29,301 cases) and pending (12,369 cases) results.","In contrast, high blood pressure increases the estimated hazard by 38% (HR=1.378, 95% CI: 1.086-1.749), immune suppression by 70% (HR=1.696, 95% CI: 1.148-2.505), diabetes by 73% (HR=1.730, 95% CI: 36.0-120.2), COPD by 77% (HR=1.770, 95% CI: 1.269-2.469), obesity by 78% (HR=1.776, 95% CI: 1.415-2.231), and chronic liver disease by 168% (HR=2.679, 95% CI: 1.789-4.014).",2020-05-01
,2020-04-23,Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis,https://doi.org/10.1016/j.jinf.2020.04.021,Journal of Infection,,,,,,,,,,,,,,,,Systematic review,13.0,"Methods The data of COVID-19 patients until March 20, 2020 were retrieved from four databases.",,,,"Results Thirteen studies were included in Meta-analysis, including a total number of 3027 patients with SARS-CoV-2 infection.","The proportion of underlying diseases such as hypertension, diabetes, cardiovascular disease, and respiratory disease were statistically significant higher in critical/mortal patients compared to the non-critical patients (diabetes: OR=3.68, 95% CI (2.68, 5.03), P < 0.00001; hypertension: OR = 2.72, 95% CI (1.60,4.64), P = 0.0002; cardiovascular disease: OR = 5.19, 95% CI(3.25, 8.29), P < 0.00001; respiratory disease: OR = 5.15, 95% CI(2.51, 10.57), P < 0.00001).

The proportion of diabetes, cardiovascular disease and respiratory disease was statistically significant higher in critical/mortal group compared to the non-critical group [diabetes:0R = 3.68, 95% CI (2.68, 5.03), P < 0.00001;cardiovascular disease: OR = 5.19, 95% CI (3.25, 8.29) , P < 0.00001; respiratory disease: OR = 5.15, 95% CI (2.51, 10.57), P < 0.00001]( Figure 3 ).",2020-05-01
,2020-04-23,COVID-19 Pandemic: A pragmatic plan for Ayurveda Intervention,https://doi.org/10.1016/j.jaim.2020.04.002,Journal of Ayurveda and Integrative Medicine,,,,,,,,,,,,,,,,Other,,TCM was officially included in the Chinese Guideline on diagnosis and treatment of COVID-19 .,,,,There are total 7.73 lakh registered AYUSH practitioners including 4.28 lakh Ayurveda practitioners .,"China's experience of pandemic has built the evidences that comorbidity such as hypertension, diabetes, coronary heart diseases and cerebrovascular disease act as risk factor with increased risk of mortality .",2020-05-01
,2020-04-23,"Clinical Characteristics of 20,662 Patients with COVID-19 in mainland China: A Systemic Review and Meta-analysis",https://doi.org/10.1101/2020.04.18.20070565,medrxiv,,,,,,,,,,,,,,,,Systematic review,20662.0,"We searched the PubMed, Embase, Scopus, Web of Science, Cochrane Library, bioRxiv, medRxiv, and SSRN databases for studies related to COVID-19 published or preprinted in English or Chinese from January 1 to March 15, 2020.",,,,"A total of 20,662 patients with COVID-19 were included.","Of 8028 patients with COVID-19, 3066 (38.52%, 95%CI 34.17-43.42%) had at least one comorbidity, including hypertension (20.78%), diabetes (12.04%), cardiovascular disease (8.58%), cerebrovascular diseases (6.01%), chronic obstructive pulmonary disease (4.20%), chronic liver disease (4.19%), malignancy (3.92%), and chronic renal disease (3.11%).",2020-05-01
,2020-04-22,Coronavirus Disease (COVID-19) Pandemic: An Overview of Systematic Reviews,https://doi.org/10.1101/2020.04.16.20068213,medrxiv,,,,,,,,,,,,,,,,Systematic review,1063.0,"Methods: Nine databases (Medline, EMBASE, Cochrane Library, CINAHL, Web of Sciences, PDQ-Evidence, WHO's Global Research, LILACS and Epistemonikos) were searched from December 1, 2019 to March 24, 2020.",,,,"Our search retrieved 1,063 publications, of which 175 were duplicates.","The most common comorbidities were hypertension (17±7, 95% CI 14-22%), diabetes (8±6, 95% CI 6-11%), cardiovascular diseases (5±4, 95% CI 4-7%) and respiratory system diseases (2±0, 95% CI 1-3%).

There was a higher likelihood that patients with severe disease had hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory disease (OR 2.46, 95% CI: 1.76-3.44), or cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22), compared with patients with non-severe disease.

The most prevalent comorbidities among confirmed cases of COVID-19 were hypertension (17.1%), cardiocerebrovascular disease (16.4%) and diabetes (9.7%).

Patients with severe disease/in ICU were more likely to have hypertension, cardio-cerebrovascular diseases and diabetes than patients with non-severe disease/not in ICU; 8.0% of patients with COVID-19 suffered acute cardiac injury.",2020-05-01
,2020-04-20,Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19,https://doi.org/10.1016/j.apsb.2020.04.008,Acta Pharmaceutica Sinica B,,,,,,,,,,,,,,,,Other,12.0,"As of February 8, 2020, 124 confirmed COVID-19 cases had been identified from Zhongnan Hospital of Wuhan University (Table 1)",,,,"In contrast, for the 12 severely ill patients in the control group, 4 patients (33.3%) were discharged, 2 patients (16.7%) were in remission, and 2 patients (16.7%) died, respectively.","Comorbidities, including diabetes mellitus, cardiovascular, and cerebrovascular diseases, were found in 6 patients in each of the DIP and control groups.",2020-04-24
,2020-04-18,Current data on the cardiovascular effects of the COVID-19,https://doi.org/10.1016/j.hjc.2020.04.001,Hellenic Journal of Cardiology,,,,,,,,,,,,,,,,Other,150.0,"disease of 2019 , and at the middle of March 2020 announced COVID-19 outbreak a pandemic.",,,,"19 An analysis of 150 patients with COVID-19, showed that among 68 fatal cases, 5 people (7%) with myocardial damage died of circulatory and 22 (33%) died of both myocardial damage and respiratory failure.","5 Similarly, in a meta-analysis that included 1527 subjects with COVID-19 the prevalence of hypertension, as well as cardiac and cerebrovascular disease was 17.1% and 16.4%, respectively.",2020-04-24
,2020-04-16,Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis,https://doi.org/10.1101/2020.04.12.20062869,medrxiv,,,,,,,,,,,,,,,,Systematic review,3473.0,"Searched Databases included PubMed, Embase, Scopus, Web of Science, Cochrane Library, medRxiv pre-print database as well as Science Direct search engine.",,,,Results: Sixteen papers including 3473 patients entered into meta-analysis for ICU admission and mortality outcome and fifty-nine papers including 9509 patients for descriptive outcomes.,"Results of meta-analysis indicated that acute cardiac injury, (OR: 15.94, 95% CI 2.31-110.14), hypertension (OR: 1.92, 95% CI 1.92-2.74), heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.

Results of meta-analysis indicated that acute cardiac injury (OR: 15.94, 95% CI 2.31-110.14), Hypertension (OR: 1.92, 95% CI 1.92-2.74), Heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.

The meta-analysis showed mortality rate of acute cardiac injury and coronary heart disease were 74% (95% CI 0.30-1.18) and 48% (95% CI 0.10-0.86) among COVID-19 patients.

Odds of mortality of COVID-19 patients with heart failure was significantly higher than hypertension and other cardiovascular diseases ( Table 2) .

Pooled prevalence of cardiovascular complications observed among patients with COVID-19 included hypertension (27%), cardiovascular and cerebrovascular disease (23%), heart failure (21%), acute cardiac injury (20%), coronary heart disease (17%), myocardial damage (16%), cardiovascular disease (12%), arrhythmia (11%), cardiomyopathy (12%) and heart palpitation (6%) ( Table 4 ).

Arrhythmia (OR: 22.17, 95%CI 4.47-110.04), acute cardiac injury (OR: 19.83, 95%CI 7.85-50.13), coronary heart disease (OR: 4.19, 95%CI 1.27-13.80), cardiovascular disease (OR: 4.17, 95%CI 2.52-6.88) and hypertension (OR: 2.69, 95%CI 1.55-4.67) were also significantly associated with ICU admission in COVID-19 patients.",2020-04-24
,2020-04-13,All about COVID-19 in brief,https://doi.org/10.1016/j.nmni.2020.100678,New Microbes New Infect,,,,,,,,,,,,,,,,Other,750.0,According to coronavirus disease 2019 (COVID-19) Situation Report -71 (Data as reported by 10:00 CET 31 March 2020) 750 890 cases were globally confirmed and 36 405 persons died .,,,,According to coronavirus disease 2019 (COVID-19) Situation Report -71 (Data as reported by 10:00 CET 31 March 2020) 750 890 cases were globally confirmed and 36 405 persons died .,"ICU care is required for aged patients or patients likely to have comorbidities including hypertension, diabetes, cardiovascular diseases and cerebrovascular disorders.",2020-05-12
,2020-04-11,"Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study",https://doi.org/10.1101/2020.04.06.20054825,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,75.0,"Methods: This observational study included data from all patients with clinically confirmed COVID-19 who were admitted to the Hankou Hospital, Wuhan, China between January 5 and March 8, 2020.",,,,There were 75 patients with hypertension and 199 patients without .,"Compared to patients without hypertension, patients with hypertension were significantly older and more likely to have underlying comorbidities, including chronic renal insufficiency, cardiovascular disease, diabetes mellitus, and cerebrovascular disease.

Patients with hypertension were older and were more likely to have pre-existing comorbidities, including chronic renal insufficiency, cardiovascular disease, diabetes mellitus, and cerebrovascular disease than patients without hypertension.

Conclusions: COVID-19 patients with hypertension were significantly older and were more likely to have underlying comorbidities, including chronic renal insufficiency, cardiovascular disease, diabetes mellitus, and cerebrovascular disease.",2020-04-17
,2020-04-10,The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis,https://doi.org/10.1101/2020.04.08.20057539,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,30.0,"DESIGN, SETTING, AND PARTICIPANTS Multicenter, retrospective cohort study of 564 consecutively hospitalized patients with confirmed COVID-19 at Third Xiangya Hospital of Central South University, Changsha Public Health Treatment Center, First Hospital of Yueyang, Junshan People's Hospital of Yueyang, Central Hospital of Shaoyang, Central Hospital of Xiangtan, Second Hospital of Changde, Central Hospital of Loudi, and First Affiliated Hospital of University of South China in Hunan province from January 17, 2020 to February 28, 2020; The final date of follow-up was March 15, 2020.",,,,"Thirty patients were classified with severe pneumonia on admission and were excluded, to leave 534 patients with non-severe COVID-19 on admission for further analysis.","Characteristics Cerebrovascular disease ACEI/ARB (n = 16) 0 Non-ACEI/ARB (n = 49) 3 (6.1%) Difference (95% CI) 6.1 (-13.7 to 16.5) P 0.311

Characteristics Cardiovascular disease ACEI/ARB (n = 16) 0 Non-ACEI/ARB (n = 49) 8 (16.3%) Difference (95% CI) 16.3 (-4.6 to 29.0) P 0.084",2020-04-17
,2020-04-10,"Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults — Seattle, Washington, 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147909/,MMWR Morb Mortal Wkly Rep,,,,,,,,,,,,,,,,Other,2.0,Nasopharyngeal swabs were used to collect specimens from all residents and staff members; SARS-CoV-2 real-time reverse transcription-polymerase chain reaction assay was performed on specimens.,,,,"Following identification of two COVID-19 cases in a Seattle independent and assisted living facility, stringent preventive measures were implemented.","Mean age of residents was 86 years (range = 69-102 years); 77% were female; and 79% had one or more chronic medical conditions including chronic lung disease, diabetes mellitus, cardiovascular disease, cerebrovascular disease, renal disease, cognitive impairment, or obesity.",2020-04-24
,2020-04-09,COVID-19 and Diabetes: Knowledge in Progress,https://doi.org/10.1016/j.diabres.2020.108142,Diabetes Research and Clinical Practice,,,,,,,,,,,,,,,,Other,72314.0,"Methods We searched for articles in PubMed and Google Scholar databases till 02 April 2020, with the following keywords: “SARS-CoV-2”, “COVID-19”, “infection”, “pathogenesis”, “incubation period”, “transmission”, “clinical features”, “diagnosis”, “treatment”, “diabetes”, with interposition of the Boolean operator “AND”.",,,,"In a large Chinese report including 72,314 patients, only 2% of those infected were younger than 20 years old (20) .","One Chinese meta-analysis including 1527 patients showed that the most prevalent cardiovascular metabolic comorbidities with COVID-19 were hypertension (17.1%, 95% CI 9.9 -24.4%) and cardio-cerebrovascular disease (16.4%, 95% CI 6.6 -26.1%), followed by diabetes (9.7%, 95% CI 6.9 -12.5%).

In this report, patients with diabetes or hypertension had a 2-fold increase in risk of severe disease or requiring intensive care unit (ICU) admission, while those with cardio-cerebrovascular disease had a 3-fold increase .",2020-04-17
,2020-04-08,Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185114/,Aging (Albany NY),,,,,,,,,,,,,,,,Systematic review,1558.0,"A literature search was performed using the electronic platforms (PubMed, Cochrane Library, Embase, and other databases) to obtain relevant research studies published up to March 1, 2020.",,,,A total of 1558 patients with COVID-19 in 6 studies were enrolled in our meta-analysis eventually.,"Hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease are major risk factors for patients with COVID-19.

The meta-analysis identified hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease as significant risk factors for COVID-19 patients.

Hypertension (OR: 2.29, P<0.001), diabetes (OR: 2.47, P<0.001), chronic obstructive pulmonary disease (COPD) (OR: 5.97, P<0.001), cardiovascular disease (OR: 2.93, P<0.001), and cerebrovascular disease (OR:3.89, P=0.002)were independent risk factors associated with COVID-19 patients.

Inclusion criteria are as follows: Types of Studies: published studies reported the relationship between comorbidity and patients with COVID-19; Subjects: diagnosed patients with COVID-19; Exposure intervention: COVID-19 patients with comorbidity included: hypertension, diabetes, chronic obstructive pulmonary disease (COPD), liver disease, malignancy, renal disease, cardiovascular disease, cerebrovascular disease; Outcome indicator: the odds ratios (OR) with 95% confidence intervals (CI) for each comorbidity.

The meta-analysis shows a significant relationship between patients with severe COVID-19 and cerebrovascular disease (OR:3.89, 95% CI: 1.64-9.22, P=0.002) (Figure 2H).

The meta-analysis shows a significant relationship between patients with severe COVID-19 and cerebrovascular disease (OR:3.89, 95% CI: 1.64-9.22, P=0.002) ( Figure 2H ).

The results find that COVID-19 patients with hypertension (OR: 2.29, 95% CI: 1.69-3.10, P<0.001) (Figure 2A), diabetes (OR: 2.47, 95% CI: 1.67-3.66, P<0.001) (Figure 2B), or COPD (OR: 5.97, 95% CI: 2.49-14.29, P<0.001) (Figure 2C) had a higher risk of exacerbation.

In the clinical symptom group, we further observed that hypertension, diabetes, COPD, malignancy, and cardiovascular disease were a risk factor in COVID-19 patients.",2020-05-12
,2020-04-06,"A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138423/,PMC,,,,,,,,,,,,,,,,Other,199.0,confirmed COVID-19 patient,,,,"Currently, an RCT (Chinese Clinical Trial Register number: ChiCTR 2000029308) with 199 patients in Wuhan aims to evaluate the safety and efficacy of lopinavir and ritonavir regimen in severe COVID-19 patients.","Our overall analysis (N = 1458) showed that the leading comorbid conditions include hypertension, cardiovascular and cerebrovascular disease, and diabetes.",2020-04-10
,2020-04-01,Insight into 2019 novel coronavirus — an updated intrim review and lessons from SARS-CoV and MERS-CoV,https://doi.org/10.1016/j.ijid.2020.03.071,International Journal of Infectious Diseases,,,,,,,,,,,,,,,,Other,4.0,General information of four inpatient case studies with relatively comprehensive data were summarized in supplementary table 1.,,,,General information of four inpatient case studies with relatively comprehensive data were summarized in supplementary table 1.,"CFRs in patients with cardiovascular disease, diabetes, hypertension and respiratory disorders were as high as 10.5%, 7.3%, 6.0% and 6.3%, respectively.",2020-04-03
,2020-03-31,Genotype and phenotype of COVID-19: Their roles in pathogenesis,https://doi.org/10.1016/j.jmii.2020.03.022,"Journal of Microbiology, Immunology and Infection",,,,,,,,,,,,,,,,Other,,"Abstract COVID-19 is a novel coronavirus with an outbreak of unusual viral pneumonia in Wuhan, China, and then pandemic.",,,,The genetic and phenotypic structure of COVID-19 in pathogenesis is important.,Co-morbidities are cardiovascular and cerebrovascular disease as well as diabetes.,2020-04-10
,2020-03-30,Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis,https://doi.org/10.1101/2020.03.26.20044057,medrxiv,,,,,,,,,,,,,,,,Systematic review,49504.0,"We searched databases of Web of Science, Scopus, and PubMed without any time limitation for publications up to March 13, 2020.",,,,"Out of selected papers, a total of 49504 patients infected with CoVID-19 with age ranged between 40 to 58 years old were included in our investigation.","The meta-analysis showed that the prevalence of the underlying diseases like cardiovascular disease, diabetes, cerebrovascular disease and hypertension in COVID-19 patients were 4%, 6%, 1%, 14%, respectively.

The cardiovascular disease, diabetes, and cerebrovascular disease were reported in 12, 11, and 4 original studies, respectively.",2020-04-03
,2020-03-30,"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.25.20043133,medrxiv,,,,,,,,,,,,,,,,Systematic review,182.0,"Methods Available data from PubMed, Web of Science, China National Knowledge Infrastructure Database, WanFang Database and VIP Database, were analyzed using a fixed effects model meta-analysis to derive overall odds ratios (OR) with 95% CIs.",,,,"182 studies were retrieved, and 9 studies were finally included after selection.","There were significant correlations between COVID-19 severity and hypertension [OR=2.3 [95% CI (1.76, 3.00), P<0.01], diabetes [OR=2.67, 95% CI (1.91, 3.74), P<0.01], coronary heart disease [OR=2.85 [95% CI (1.68, 4.84), P<0.01].

In the included studies, the comorbidities of COVID-19 mainly included hypertension, diabetes, coronary heart disease, chronic liver disease, cancer/malignant tumor, and cerebrovascular disease, chronic obstructive pulmonary disease (COPD).

(c) The outcomes have the number of COVID-19 with hypertension, diabetes and coronary heart disease in severe patients and non-severe patients.",2020-04-03
,2020-03-30,Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up,https://doi.org/10.1016/j.jinf.2020.03.019,Journal of Infection,,,,,,,,,,,,,,,,Retrospective observational,339.0,"Methods Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included.",,,,"Results 339 patients with COVID-19 (aged 71±8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases.","Symptoms of dyspnea (HR 2.35, CI 1.43-3.87, P = 0.001) and comorbidities including cardiovascular disease (HR 2.87, CI 1.70-4.83, P < 0.001), cerebrovascular disease (HR 3.26, CI 1.66-6.40, P = 0.001) and COPD (HR 3.72, CI 1.94-7.13, P < 0.001) were all predictive of fatal outcomes.

Comorbidities including hypertension, cardiovascular disease, cerebrovascular disease, and COPD were more prevalent in the dead group.

Common comorbidities were hypertension (40.8%), diabetes (16.0%) and cardiovascular disease (15.7%).

Patient history were collected for comorbidities including hypertension, diabetes, cardiovascular disease, cerebrovascular disease, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease (COPD), malignancy and autoimmune diseases.

Common comorbidities included hypertension (138 cases, 40.8%), diabetes (54 cases, 16.0%) and cardiovascular disease (48 cases, 14.2%).",2020-04-17
,2020-03-28,Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules,https://doi.org/10.1016/j.bmc.2020.115466,Bioorganic & Medicinal Chemistry,,,,,,,,,,,,,,,,Other,,"Sodium houttuynin, a volatile oil, was extracted from perennial plant Houttunynia cordata Thunb.",,,,13) with no substitution at 4 and 5 positions.,"Hypertension is a fundamental hazard factor for cardiovascular disease, stroke, and chronic kidney disease.",2020-04-10
,2020-03-26,"COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis",https://doi.org/10.1101/2020.03.24.20042903,medrxiv,,,,,,,,,,,,,,,,Systematic review,4789.0,"Methods: We reviewed the scientific literature published from January 1, 2019 to March 3, 2020.",,,,A total of 4789 patients with a mean age of 49 years were evaluated.,"The most common comorbidities were respectively hypertension (18.5 %, CI 12.7-24.4), 246 cardiovascular diseases (14.9 %, CI 6.0-23.8), diabetes (10.8 %, CI 8.3-13.3), chronic liver 247 disease (8.1, CI 4.6-11.6) and smoking (8.0%, CI 2.3-13.6) ( Table 3) .

The most prevalent comorbidities were hypertension (18.5 %, CI 12.7 to 24.4) and Cardiovascular disease (14.9 %, CI 6.0 to 23.8).

The most prevalent comorbidities in our study were hypertension (18.5 %, CI 12.7-24.4) followed 307 by cardiovascular diseases (14.9 %, CI 6.0-23.8) and diabetes (10.8 %, CI 8.3-13.3).

According 308 to a systematic review for comorbidities by Yang et al, hypertension (17 ± 7%, CI 14-22%) and 309 diabetes (8 ± 6%, CI 6-11%), followed by cardiovascular diseases (5 ± 4%, CI 4-7%) were the 310 most common comorbid findings .",2020-04-03
,2020-03-26,Antihypertensive drugs and risk of COVID-19? – Authors' reply,https://doi.org/10.1016/s2213-2600(20)30159-4,The Lancet Respiratory Medicine,,,,,,,,,,,,,,,,Other,41.0,"As of March 22, 2020, 307 297 people have been infected by SARS-CoV-2, with 13 049 deaths and 92 382 people recovered.",,,,"3 In a second cohort of 41 patients hospitalised with COVID-19, 4 diabetes (20%), hypertension (15%), and cardiovascular disease (15%) were frequent comorbidities.","Of 1099 infected patients, 173 had severe disease, in whom the most common comorbidities were hypertension (24%), diabetes (16%), coronary heart disease (6%), and cerebrovascular disease (2%).",2020-05-12
,2020-03-26,Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184365/,J Crohns Colitis,,,,,,,,,,,,,,,,Other,13.0,"However, based on a PubMed search on March 17, 2020, we found no evidence to suggest that Covid-19 occurs more frequently in IBD patients than in the general population.",,,,"13 In vitro studies have shown that the latter form of ACE2 might act as a competitive interceptor of SARS-CoV-2 by preventing binding of the viral particle to the surface-bound, full-length ACE2.","with coronary heart disease, hypertension, diabetes mellitus, lung disease, cerebrovascular diseases], should stay at home and avoid public gatherings.",2020-05-12
,2020-03-23,"Clinical Characteristics of Coronavirus Disease 2019 in Hainan, China",https://doi.org/10.1101/2020.03.19.20038539,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,168.0,Methods: We conducted a retrospective study included all 168 confirmed cases of Covid-19 in Hainan province from 22 January 2020 to 13 March 2020.,,,,Methods: We conducted a retrospective study included all 168 confirmed cases of Covid-19 in Hainan province from 22 January 2020 to 13 March 2020.,"On admission, 24 (14.3%), 12 (7.1%), and 12 (7.1%) patients are with history of hypertension, diabetes, and cardiovascular disease, respectively.",2020-03-27
,2020-03-23,The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study,https://doi.org/10.1101/2020.03.16.20036145,medrxiv,,,,,,,,,,,,,,,,Other,10.0,Graphs were plotted using GraphPad Prism 7.0.,,,,"From January 23, 2020, to February 19, 2020, ten severe COVID-19 patients (six males and four females) were enrolled and received CP transfusion.","Four patients had underlying chronic diseases, including cardiovascular and/or cerebrovascular diseases and essential hypertension.",2020-03-27
,2020-03-12,Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis,https://doi.org/10.1016/j.ijid.2020.03.017,Int J Infect Dis,,,,,,,,,,,,,,,,Systematic review,576.0,"A systematic search was conducted on studies published from January 1, 2019 to February 25, 2020 in PubMed, EMBASE, and Web of Science databases.",,,,"As of February 25, 2020, a total of 1 576 participants were included in our meta-analysis.","Higher risk of hypertension (OR 2.36, 95% CI: 1.46–3.83), respiratory system disease (OR 2.46, 95% CI: 1.76–3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88–6.22) were observed in the severe group.

Higher risk of hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory system disease (OR 2.46, 95% CI: 1.76-3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22) were observed in the severe group.

The most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0-27.2%) and diabetes (9.7%, 95% CI: 7.2-12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8-13.8%) and respiratory system disease (1.5%, 95% CI: 0.9-2.1%).

When compared between severe and non-severe patients, the pooled OR of hypertension, respiratory system disease, and cardiovascular disease were 2.36 (95% CI: 1.46–3.83), 2.46 (95% CI: 1.76–3.44) and 3.42 (95% CI: 1.88–6.22) respectively.

The comorbidities included hypertension, diabetes, respiratory system disease, and cardiovascular disease.",2020-05-12
,2020-03-11,Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China,https://doi.org/10.1007/s00392-020-01626-9,Clinical Research in Cardiology,,,,,,,,,,,,,,,,Systematic review,6.0,Embase and PubMed were searched for relevant studies.,,,,RESULTS: A total of six studies with 1527 patients were included in this analysis.,"The proportions of hypertension, cardia-cerebrovascular disease and diabetes in patients with COVID-19 were 17.1%, 16.4% and 9.7%, respectively.",2020-03-27
,2020-03-11,Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?,https://doi.org/10.1016/s2213-2600(20)30116-8,Lancet Respir Med,,,,,,,,,,,,,,,,Other,140.0,"In a third study, 3 of 140 patients who were admitted to hospital with COVID-19, 30% had hypertension and 12% had diabetes.",,,,"In a third study,3 of 140 patients who were admitted to hospital with COVID-19, 30% had hypertension and 12% had diabetes.","Another study 2 included 1099 patients with confirmed COVID-19, of whom 173 had severe disease with comorbidities of hypertension (23·7%), diabetes mellitus (16·2%), coronary heart diseases (5·8%), and cerebrovascular disease (2·3%).

Another study2 included 1099 patients with confirmed COVID-19, of whom 173 had severe disease with comorbidities of hypertension (23·7%), diabetes mellitus (16·2%), coronary heart diseases (5·8%), and cerebrovascular disease (2·3%).",2020-04-10
,2020-03-06,"Clinical characteristics of 101 non-surviving hospitalized patients with COVID-19: A single center, retrospective study",https://doi.org/10.1101/2020.03.04.20031039,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,101.0,Methods: 101 non-surviving patients with confirmed COVID-19 were included in this retrospective study.,,,,Methods: 101 non-surviving patients with confirmed COVID-19 were included in this retrospective study.,"The most common comorbidities included hypertension (58.4%), cardiovascular disease (22.8%), diabetes (20.8%), chronic pulmonary disease (14.9%), cerebrovascular disease (12.9%) ( Table 1 ).",2020-04-24
,2020-03-03,"Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China",https://doi.org/10.1101/2020.03.02.20029306,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,110.0,"Results: A total of 110 patients diagnosed with 2019 novel coronavirus pneumonia were included in the study, including 38 with severe pneumonia and 72 with non-severe pneumonia.",,,,"Results: A total of 110 patients diagnosed with 2019 novel coronavirus pneumonia were included in the study, including 38 with severe pneumonia and 72 with non-severe pneumonia.",incidence of diabetes and cerebrovascular disease was similar in both groups.,2020-03-27
,2020-02-27,Clinical characteristics of 82 death cases with COVID-19,https://doi.org/10.1101/2020.02.26.20028191,medrxiv,,,,,,,,,,,,,,,,Case series,1334.0,"We retrospectively collected epidemiological and clinical features of laboratory-confirmed COVID-19 dead patients from January 11, 2020 to February 10, 2020 in the Renmin Hospital, Wuhan University.",,,,"From January 11, 2020 to February 10, 2020, a total of 1,334 patients with a diagnosis of laboratory-confirmed COVID-19 were recorded in the Renmin Hospital, Wuhan University, while 6.2% (82/1334) of patients with this disease were dead.","The bulk of death cases had comorbidity (76.8%), including hypertension (56.1%), heart disease (20.7%), diabetes (18.3%), cerebrovascular disease (12.2%), and cancer (7.3%).

Age, years Cerebrovascular 72.5 (65.0-80.0) 10/82 (12.2)

  of death cases had comorbidity (75.6%), including hypertension (56.1%), heart disease (20.7%), diabetes (18.3%), cerebrovascular disease (12.2%), and cancer (7.3%).",2020-03-27
,2020,"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): Facts and myths",https://doi.org/10.1016/j.jmii.2020.02.012,"Journal of Microbiology, Immunology and Infection",,,,,,,,,,,,,,,,Other,9.0,"As of February 21, 2020, data from the WHO revealed altogether 76,769 cases of COVID-19.",,,,"Regarding children with COVID-19, nine (0.9%) patients aged 0-14 years were found in only one study, 11 while 14 (0.35%) patients were aged ≤ 10 years in another study.","showed that 50.5% (n Z 51) of patients had chronic medical illness, namely cardiovascular and cerebrovascular diseases (40.4%).",2020-04-17
0,2020-04-25,The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails,http://doi.org/10.1101/2020.04.21.20074633,,OR 3.94,0.88,17.59,,Not Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,4 studies,"PubMed, Scopus, EMBASE, Web of Science, and Google Scholar searched through March 12 2024",5/6/2020,Y,N,,,
1,2020-04-15,Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Q28,http://doi.org/10.1016/j.chest.2020.04.010,,,,,,,,,HR 3.1,1.07,8.97,,Significant,Adjusted,Extracted,"Age, cardiovascular disease, dyspnea, procalcitonin, AST",Retrospective observational study,1590,"575 hospitals in China through January 31, 2020",5/6/2020,N,N,,,
2,2020-04-03,History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study,https://doi.org/10.1101/2020.03.23.20041848,medRxiv,,,,,,,,AHR 1.9,0.9,3.8,0.07,Not Significant,Adjusted,Extracted,"Age, gender, admitted before 1/11/2020, COPD, renal failure, heart disease",Retrospective observational study,275,"mainland China outside of Hubei Province, from December 18th, 2019 to March 8, 2029",4/10/2020,N,N,,,
3,2020-04-03,History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study,https://doi.org/10.1101/2020.03.23.20041848,medRxiv,,,,,,,,HR 2.9,1.4,5.8,<0.01,Significant,Not Adjusted,Extracted,,Retrospective observational study,275,"mainland China outside of Hubei Province, from December 18th, 2019 to March 8, 2023",4/10/2020,N,N,,,
4,2020-04-02,Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up,https://www.journalofinfection.com/article/S0163-4453(20)30146-8/pdf,Journal of Infection,,,,,,,,HR 3.26,1.66,6.4,<0.01,Significant,Not Adjusted,Extracted,,Prospective observational study,339,"age over 60 years old admitted to Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 (followed up until March 5)",4/10/2020,N,N,,,
5,2020-03-24,"Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study",https://doi.org/10.1101/2020.03.21.20040121,medRxiv,,,,,,,Previous stroke,OR 2.84,0.71,11.28,0.14,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,110,Patients from Wuhan No.1 Hospital from Dec 25th to Feb 15th.,4/10/2020,N,N,,,
6,2020-03-23,Prognostic value of C-reactive protein in patients with COVID-19,https://doi.org/10.1101/2020.03.21.20040360,medRxiv,,,,,,,,OR: 3.37,1.59,7.11,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,298,"Eastern Campus of Renmin Hospital of Wuhan University from Jan 30 to Feb 20, 2025",4/10/2020,N,Y,,,
7,2020-03-17,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.17.20037572,medRxiv,OR 3.22,1.49,6.97,,Significant,Not Adjusted,Calculated,,,,,,,,Cerebrovascular disease,Systematic review and meta-analysis,5 studies enrolling 2197 patients,"PubMed, Web of Science Core Collection, Embase, Cochrane and MedRxiv databases were searched through February 25, 2020.",4/10/2020,N,N,,,
8,2020-03-13,Epidemiological characteristics of confirmed COVID-19 cases in Tianjin,https://doi.org/10.3760/cma.j.cn112338-20200221-00146,Chinese Journal of Epidemiology,OR 2.48,1.14,5.4,,Significant,Not Adjusted,Extracted,,,,,,,,,Cross-sectional study,135,Tianjin from Jan 11-Feb 14,4/10/2020,N,N,,,
